Quan Lin

机构：First Hospital of Shijiazhuang · ORCID：0000-0001-5842-8032

发表论文 47 篇 · 总被引 768 次 · h-index 12

代表论文

• Autologous T cell therapy for MAGE-A4+ solid cancers in HLA-A*02+ patients: a phase 1 trial (2023 · Nature Medicine · 被引 200)
• Neoadjuvant Osimertinib for Resectable EGFR -Mutated Non–Small Cell Lung Cancer (2025 · Journal of Clinical Oncology · 被引 76)
• Characterization of Chitosan‐Gallic Acid Graft Copolymer for Periodontal Dressing Hydrogel Application (2023 · Advanced Healthcare Materials · 被引 60)
• Antibiofilm Effect of Cinnamaldehyde-Chitosan Nanoparticles against the Biofilm of Staphylococcus aureus (2022 · Antibiotics · 被引 53)
• Intratumour microbiome of pancreatic cancer (2023 · World Journal of Gastrointestinal Oncology · 被引 36)
• Weighted gene coexpression network analysis and machine learning reveal oncogenome associated microbiome plays an important role in tumor immunity and prognosis in pan-cancer (2023 · Journal of Translational Medicine · 被引 28)